Literature DB >> 28436962

Cancer immunotherapy: Making allies of phagocytes.

Steven Fiering1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28436962     DOI： 10.1038/nnano.2017.89

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN： 1748-3387            Impact factor:   39.213


× No keyword cloud information.
  5 in total

1.  Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil): profile report.

Authors:  M Asif A Siddiqui; Caroline M Perry
Journal:  BioDrugs       Date:  2006       Impact factor: 5.807

2.  Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

Authors:  Juan R Cubillos-Ruiz; Xavier Engle; Uciane K Scarlett; Diana Martinez; Amorette Barber; Raul Elgueta; Li Wang; Yolanda Nesbeth; Yvon Durant; Andrew T Gewirtz; Charles L Sentman; Ross Kedl; Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

Review 3.  The host STING pathway at the interface of cancer and immunity.

Authors:  Leticia Corrales; Sarah M McWhirter; Thomas W Dubensky; Thomas F Gajewski
Journal:  J Clin Invest       Date:  2016-07-01       Impact factor: 14.808

4.  In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.

Authors:  P H Lizotte; A M Wen; M R Sheen; J Fields; P Rojanasopondist; N F Steinmetz; S Fiering
Journal:  Nat Nanotechnol       Date:  2015-12-21       Impact factor: 39.213

5.  STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling.

Authors:  Hiroki Ishikawa; Glen N Barber
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962
  5 in total
  4 in total

1.  Biomimetic Nanoparticle Vaccines for Cancer Therapy.

Authors:  Ashley V Kroll; Yao Jiang; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Biosyst       Date:  2018-11-13

Review 2.  Immuno-Oncology: Emerging Targets and Combination Therapies.

Authors:  Henry T Marshall; Mustafa B A Djamgoz
Journal:  Front Oncol       Date:  2018-08-23       Impact factor: 6.244

Review 3.  Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.

Authors:  Christine E Boone; Lu Wang; Aayushma Gautam; Isabel G Newton; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-07-22

Review 4.  Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy.

Authors:  Chiara Cremolini; Emanuela Vitale; Raffaella Rastaldo; Claudia Giachino
Journal:  Nanomaterials (Basel)       Date:  2021-03-08       Impact factor: 5.076
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.